Baxter International (NYSE:BAX) had a weak trading session and its shares were last down at $44.53, down -0.04% or -0.09 points. The trading data also revealed that the total net flow stood at $13.47 million as the shares had $16.08 million in upticks but lost $2.6 million in downticks. The up/down ratio was 6.17. This data is particularly important for the traders and speculators alike as it could also be used to gauge the strength of the momentum in the shares. During the past week, the shares have seen a change of 0.09% in the shares.The block trade data suggests an inflow of $13.82 million in upticks and an outflow of $0 million in downticks. The up/down ratio for the block stood at 0. The net money flow for this transaction was recorded at $13.82.
Baxter International Inc. has lost 0.11% in the last five trading days and dropped 1.12% in the last 4 weeks. Baxter International Inc. is up 11.07% in the last 3-month period. Year-to-Date the stock performance stands at 17.18%.
Currently the company Insiders own 1.08% of Baxter International shares according to the proxy statements. Institutional Investors own 84.39% of Baxter International shares. During last six month period, the net percent change held by insiders has seen a change of -23.18%. . On the companys insider trading activities, Almeida Jose E, CEO of Baxter International Inc, had purchased 11,691 shares on May 23, 2016. The total value of the transaction was $499,790. The information was disclosed with the SEC in a Form 4 Filing. The information is based on open market trades at the market prices.Option exercises are not covered.
Baxter International (NYSE:BAX) witnessed a decline in the market cap on Friday as its shares dropped 0.29% or 0.13 points. After the session commenced at $44.63, the stock reached the higher end at $44.6697 while it hit a low of $44. With the volume soaring to 5,158,086 shares, the last trade was called at $44.44. The company has a 52-week high of $46.95. The company has a market cap of $24,543 million and there are 552,262,740 shares in outstanding. The 52-week low of the share price is $32.18.
Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment, which include three commercial franchises: Hemophilia, BioTherapeutics and BioSurgery, and Medical Products segment, which include four commercial franchises: Fluid Systems, Renal, Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions, and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anesthetics. Its products are used in hospitals, kidney dialysis centers and nursing homes, among others.